7 completed, 3 terminated, 1 active not recruiting, 1 unknown. 12 Phase 2, 7 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 12 | Completed 7, Terminated 3, Active not recruiting 1, Unknown 1 |
| Phase 1 | 7 | Terminated 3, Completed 2, Active not recruiting 1, Unknown 1 |
Follow Interleukin-12: new trials by email Literature Review of Interleukin-12 trials Research Report on Interleukin-12
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-naïve GBM Patients. Dendritic Cell/Tumor Fusion Vaccine, Interleukin-12, Temozolomide - Glioblastoma, Glioma | Phase 1 / Phase 2 | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 10 | 2020-12-01 | 2020-06-09 |
| Cetuximab and Recombinant Interleukin-12 in Treating Patients With Squamous Cell Carcinoma of the Head and Neck That is Recurrent, Metastatic, or Cannot Be Removed by Surgery Cetuximab, Edodekin alfa, Laboratory Biomarker Analysis - Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma | Phase 1 / Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 23 | 2011-10-26 | 2026-11-18 |
| Vaccination of Patients With Breast Cancer With Dendritic Cell/Tumor Fusions and IL-12 Dendritic Cell/Tumor Fusion Vaccine, Interleukin-12 - Breast Cancer | Phase 1 / Phase 2 | Terminated | Beth Israel Deaconess Medical Center | 8 | 2009-12-01 | 2017-11-14 |
| Interleukin-12 and Interleukin-2 in Treating Patients With Mycosis Fungoides aldesleukin, recombinant interleukin-12, laboratory biomarker analysis - Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome | Phase 1 / Phase 2 | Terminated | National Cancer Institute (NCI) | 46 | 2002-09-01 | 2013-01-16 |
| Vaccine Therapy Plus Interleukin-12 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy PSA prostate cancer vaccine, recombinant interleukin-12 - Prostate Cancer | Phase 2 | Completed | University of Chicago | 13 | 2001-11-01 | 2014-03-07 |
| Rituximab and Interleukin-12 in Treating Patients With B-Cell Non-Hodgkin's Lymphoma rituximab, recombinant interleukin-12, laboratory biomarker analysis - Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Nodal Marginal Zone B-cell Lymphoma | Phase 2 | Completed | National Cancer Institute (NCI) | 99 | 2001-10-01 | 2013-08-26 |
| Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Malignant Melanoma recombinant interleukin-12, recombinant interferon alfa, laboratory biomarker analysis - Recurrent Melanoma, Stage IV Melanoma | Phase 2 | Completed | National Cancer Institute (NCI) | 60 | 2001-10-01 | 2013-06-05 |
| Interleukin-12 in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer recombinant interleukin-12 - Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer | Phase 2 | Completed | National Cancer Institute (NCI) | 30 | 2001-07-01 | 2013-01-23 |
| Gene Therapy in Treating Patients With Unresectable, Recurrent, or Refractory Head and Neck Cancer IL-12 - Head and Neck Cancer | Phase 1 / Phase 2 | Completed | Dana-Farber Cancer Institute | 7 | 1999-07-01 | 2017-04-20 |
| Interleukin-12 in Treating Patients With Previously Treated Non-Hodgkin's Lymphoma or Hodgkin's Disease recombinant interleukin-12, laboratory biomarker analysis - Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Nodal Marginal Zone B-cell Lymphoma | Phase 2 | Completed | National Cancer Institute (NCI) | 105 | 1998-02-01 | 2015-04-15 |
| Interleukin 12 (IL-12) for the Treatment of Cryptosporidiosis in AIDS Patients IL-12 - HIV Infections, Cryptosporidiosis | Phase 1 / Phase 2 | Terminated | National Institute of Allergy and Infectious Diseases (NIAID) | 2 | 1997-09-01 | 2016-12-14 |
| Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma interleukin-12 - Epidemic Kaposi's Sarcoma, Recurrent Kaposi's Sarcoma | Phase 1 / Phase 2 | Completed | National Cancer Institute (NCI) | 1997-01-01 | 2024-03-04 |
Leukemia, Lymphocytic, Chronic, B-Cell (2) · Lymphoma, B-Cell, Marginal Zone (2) · Lymphoma, Follicular (2) · Lymphoma, Mantle-Cell (2) · Lymphoma, T-Cell, Cutaneous (2) · Mycosis Fungoides (2) · Neoplasms (2) · Sezary Syndrome (2) · Squamous Cell Carcinoma of Head and Neck (2) · AIDS-related Kaposi sarcoma (1) · Breast Neoplasms (1) · Carcinoma, Ovarian Epithelial (1) · Cryptosporidiosis (1) · Glioblastoma (1) · Glioma (1)
National Cancer Institute (NCI) (7) · Beth Israel Deaconess Medical Center (1) · Dana-Farber Cancer Institute (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Second Affiliated Hospital, Zhejiang University, School of Medicine (1) · University of Chicago (1)
United States (10) · China (1)
A. Dimitrios Colevas, MD (1) · Alain Rook (1) · Anas Younes (1) · Arthur White (1) · David Avigan, MD (1) · Hong Shen, MD (1) · Renato Lenzi (1) · Robert Yarchoan (1) · Stephen Ansell (1) · Thomas F. Gajewski, MD, PhD (1) · William Carson (1) · William E Carson (1)
N01CM17003 (2), P30CA006516 (2), N01CM00070 (1), P30CA016058 (1), R01AI041735 (1), R01CA089442 (1), U01CA062490 (1), U01CA076576 (1), U10CA025224 (1), U10CA031946 (1), UM1CA186712 (1)